Sharecafe

Chimeric Therapeutics (ASX:CHM) – Webinar Presentation

Jennifer Chow - CEO & Managing Director - Chimeric Therapeutics (ASX:CHM) is a clinical-stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer.

 

Jennifer Chow – CEO & Managing Director – Chimeric Therapeutics (ASX:CHM) is a clinical-stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer.

Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X

All Categories